Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells

被引:14
作者
Borgdorff, V [1 ]
van Hees-Stuivenberg, S [1 ]
Meijers, CM [1 ]
de Wind, N [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 AL Leiden, Netherlands
关键词
DNA mismatch repair; loss of heterozygosity; genotoxic agents; hereditary nonpolyposis colorectal cancer;
D O I
10.1016/j.mrfmmm.2005.01.021
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have developed a simple procedure that enables the efficient selection of cells that are deficient for DNA mismatch repair (MMR). This selection procedure was used to investigate the frequency of fortuitous MMR-deficient cells in a mouse embryonic stem cell line, heterozygous for the MMR gene Msh2. We found a surprisingly high frequency (3 x 10(-4)) of Msh2-deficient cells. The wild type Msh2 allele was almost invariably lost by loss of heterozygosity. Single treatments with the genotoxic agents ethylnitrosourea, UVC light and mitomycin C resulted in a further increase of the number of Msh2(-/-) cells in the heterozygous cell line. This increase was not only due to induced loss of the wild type allele but also to a selective growth advantage of preexisting Msh2(-/-) cells to ethylnitrosourea and UVC. Mitomycin C, in contrast to ethylnitrosourea and UVC, uniquely induced loss of heterozygosity at Msh2. These mechanistically different ways of loss of the wild type Msh2 allele reflect the different repair pathways processing these damages. Heterozygous germ line defects in one of the MMR genes underlie the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Based on the results described here we hypothesize that mutagen-induced loss of MMR in the intestine of these patients contributes to the tissue specificity of carcinogenesis in HNPCC patients. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 30 条
  • [1] DISTRIBUTION OF METHYL AND ETHYL ADDUCTS FOLLOWING ALKYLATION WITH MONOFUNCTIONAL ALKYLATING-AGENTS
    BERANEK, DT
    [J]. MUTATION RESEARCH, 1990, 231 (01): : 11 - 30
  • [2] Berry SE, 2000, CANCER RES, V60, P5773
  • [3] Unmasking a killer:: DNA O6-methylguanine and the cytotoxicity of methylating agents
    Bignami, M
    O'Driscoll, M
    Aquilina, G
    Karran, P
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (2-3) : 71 - 82
  • [4] Mitomycin C: a clinical update
    Bradner, WT
    [J]. CANCER TREATMENT REVIEWS, 2001, 27 (01) : 35 - 50
  • [5] Mammalian DNA mismatch repair
    Buermeyer, AB
    Deschênes, SM
    Baker, SM
    Liskay, RM
    [J]. ANNUAL REVIEW OF GENETICS, 1999, 33 : 533 - 564
  • [6] Embryonic stem cells and somatic cells differ in mutation frequency and type
    Cervantes, RB
    Stringer, JR
    Shao, CS
    Tischfield, JA
    Stambrook, PJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) : 3586 - 3590
  • [7] Claij N, 2003, CANCER RES, V63, P2062
  • [8] HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and MSh6 mismatch-repair protein functions
    de Wind, N
    Dekker, M
    Claij, N
    Jansen, L
    van Klink, Y
    Radman, M
    Riggins, G
    van der Valk, M
    van 't Wout, K
    Riele, HT
    [J]. NATURE GENETICS, 1999, 23 (03) : 359 - 362
  • [9] Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation
    DeWeese, TL
    Shipman, JM
    Larrier, NA
    Buckley, NM
    Kidd, LR
    Groopman, JD
    Cutler, RG
    te Tiele, H
    Nelson, WG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11915 - 11920
  • [10] INACTIVATION OF THE MOUSE MSH2 GENE RESULTS IN MISMATCH REPAIR DEFICIENCY, METHYLATION TOLERANCE, HYPERRECOMBINATION, AND PREDISPOSITION TO CANCER
    DEWIND, N
    DEKKER, M
    BERNS, A
    RADMAN, M
    RIELE, HT
    [J]. CELL, 1995, 82 (02) : 321 - 330